Skip to content

Zip Incision Approximation vs. Suture for C-Section

A Prospective, Non-blinded, Randomized Controlled Post-market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device Versus Sutures for Skin Closure in Subjects Who Undergo a Cesarean Section Procedure.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02915952
Acronym
ZIPS-C
Enrollment
60
Registered
2016-09-27
Start date
2016-08-31
Completion date
2018-01-31
Last updated
2017-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C.Surgical Procedure; Dehiscence, Cesarean Section

Brief summary

The study will evaluate the ZipLine Medical Surgical Skin Closure device (Zip)versus sutures when utilized for skin layer closure during wound closure of Cesarean Section Procedure.

Detailed description

Cesarean-section birth is a very invasive surgical procedure. While the desired outcome focuses primarily on the successful delivery of a healthy baby and maintenance of the mother's health, the surgery involves a complex surgical closure process, starting with the uterus, and progressing through several layers of traditionally suture closure in several tissue planes. A successful closure results in no surgical site complications, with good patient comfort and a minimal scar being a desired outcome. Conventional skin closure methods such as sutures are effective but have drawbacks. It has been suggested that the ideal method of wound / incision closure should be: * fast * non-traumatic * minimally or non-invasive * associated with a low incidence of adverse events such as dehiscence and infection * yielding acceptable cosmetic results ZipLine Medical, Inc. is a Campbell, California-based company that has developed a novel, non-invasive skin closure device called Zip Surgical Skin Closure to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. In the USA, the device has been classified by the FDA as a Class I, 510(k) Exempt device and began commercial use in the USA in April 2013. The ZipLine Device has been clinically demonstrated benefits include (references included later in this document): * Closure speed faster/superior to (and less variable compared to) sutures * Suture-like cosmetic outcome * Reduction in post-surgical care costs * Fewer closure-related wound issues * Greater patient satisfaction

Interventions

The Zip Surgical Skin Closure Device will be used for surgical wound closure in C-Section Surgery

OTHERConventional Sutures

Conventional Sutures will be used for surgical wound closure in C-Section Surgery

Sponsors

ZipLine Medical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients 18 years of age and older 2. Primary C-section 3. Patients willing and able to complete study protocol

Exclusion criteria

1. Known bleeding disorder not caused by medication 2. Known personal or family history of keloid formation or scar hypertrophy 3. Known allergy or hypersensitivity to non-latex skin adhesives 4. Atrophic skin deemed clinically prone to blistering 5. Any skin disorder affecting wound healing 6. Any other condition that in the opinion of the investigator would make a particular subject unsuitable for this study 7. Emergent C-Section 8. Non-primary C-Section

Design outcomes

Primary

MeasureTime frameDescription
Time of Procedure ClosureProcedure Closure - Zip or Suture touches skin until skin is closedUpon closure of the Cesarean incision - Zip or Suture touches skin to close incision
Cosmetic Visual Analogue Scale (CVAS)3 months100-mm Cosmetic Visual Analogue Scale (CVAS) for incision appearance

Secondary

MeasureTime frameDescription
Surgeon Closure Method SatisfactionProcedure, 3-5 days, 3 monthsSatisfaction with closure method, scar appearance
Patient Closure Method Satisfaction3-5 days, 14 days, 3 monthsSatisfaction with closure method, scar appearance
Patient Pain and Discomfort by Subject Questionnaire3-5 days, 14 days, 3 monthsPain associated with the closure method and level of discomfort during use will be asked by questionnaire
Incidence and severity of Adverse EventsProcedure, 3-5 days, 14 days, 3 monthsThe incidence and severity of adverse events (AE) associated with Zip device and control will be evaluated

Countries

Israel

Contacts

Primary ContactWendy M Winters
wwinters0@gmail.com408-506-1866
Backup ContactEric Storne
estorne@ziplinemedical.com888-326-8999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026